Indication
Mucopolysaccharidosis type VII
Mucopolysaccharidosis type VII, also known as Sly syndrome, is an extremely rare, progressive autosomal recessive lysosomal storage disease caused by a deficiency of the enzyme beta-glucuronidase. Read more about Mucopolysaccharidosis type VII
1 drugs 1 manufacturers
Drugs that treat it
Common Mucopolysaccharidosis type VII therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMucopolysaccharidosis type VII, also known as Sly syndrome, is an extremely rare, progressive autosomal recessive lysosomal storage disease caused by a deficiency of the enzyme beta-glucuronidase.
This enzymatic defect prevents the degradation of glycosaminoglycans, leading to pathological substrate accumulation across multiple organ systems, including the skeleton, central nervous system, heart, liver, and spleen.
Clinical manifestations range in severity from fatal non-immune hydrops fetalis in utero to attenuated childhood- or adult-onset forms characterized by skeletal dysplasia (dysostosis multiplex), short stature, hepatosplenomegaly, coarse facial features, corneal clouding, cardiac valve abnormalities, and variable intellectual impairment.
- medlineplus.gov
Mucopolysaccharidosis type VII, also known as Sly syndrome, is an extremely rare, progressive autosomal recessive lysosomal storage disease caused by a deficiency of the enzyme beta-glucuronidase This enzymatic defect prevents the degradation of glycosaminoglycans, leading to pathological substrate accumulation across multiple organ systems, including the skeleton, central nervous system, heart, liver, and spleen Clinical manifestations range in severity from fatal non-immune hydrops fetalis in ...
- rarediseases.org
Mucopolysaccharidosis type VII, also known as Sly syndrome, is an extremely rare, progressive autosomal recessive lysosomal storage disease caused by a deficiency of the enzyme beta-glucuronidase This enzymatic defect prevents the degradation of glycosaminoglycans, leading to pathological substrate accumulation across multiple organ systems, including the skeleton, central nervous system, heart, liver, and spleen Clinical manifestations range in severity from fatal non-immune hydrops fetalis in ...
- mpsviiinfocus.com
Mucopolysaccharidosis type VII, also known as Sly syndrome, is an extremely rare, progressive autosomal recessive lysosomal storage disease caused by a deficiency of the enzyme beta-glucuronidase
- nih.gov
Clinical manifestations range in severity from fatal non-immune hydrops fetalis in utero to attenuated childhood- or adult-onset forms characterized by skeletal dysplasia (dysostosis multiplex), short stature, hepatosplenomegaly, coarse facial features, corneal clouding, cardiac valve abnormalities, and variable intellectual impairment
Personalize your experience
Follow Mucopolysaccharidosis type VII and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.